The genetics of sporadic colon cancer

Seminars in Colon and Rectal Surgery

Volumn 15, Issue 3, 2004, Pages 128-135

  Chung, T Philip ^a   Fleshman, James W ^a,b,c  

^a WASHINGTON UNIVERSITY   (United States)

^b Washington University in St Louis School of Medicine   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTISENSE OLIGODEOXYNUCLEOTIDE; APC PROTEIN; BEVACIZUMAB; CYCLOOXYGENASE 2 INHIBITOR; DNA; K RAS PROTEIN; MATRIX METALLOPROTEINASE; MISMATCH REPAIR PROTEIN PMS2; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN BAX; PROTEIN BCL 2; PROTEIN MLH1; PROTEIN MSH2; PROTEIN P53; SOMATOMEDIN B RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; VASCULOTROPIN;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CELL HYPERPLASIA; CHROMOSOMAL INSTABILITY; CHROMOSOME 18Q; CLINICAL TRIAL; COLON ADENOMA; COLON CANCER; COLON CARCINOGENESIS; COLON CARCINOMA; COLONOSCOPY; COLORECTAL CARCINOMA; DNA DAMAGE; DNA REPAIR; DRUG TARGETING; ENDOMETRIUM CANCER; FAMILIAL COLON POLYPOSIS; FIBERSCOPE ENDOSCOPY; GARDNER SYNDROME; GENE DELETION; GENE MUTATION; GENE TARGETING; HETEROZYGOSITY LOSS; HUMAN; LIVER METASTASIS; LYMPH NODE METASTASIS; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MOLECULAR GENETICS; NONHUMAN; NUCLEOTIDE REPEAT; ONCOGENE; POLYMERASE CHAIN REACTION; PROGNOSIS; RECURRENT CANCER; REGULATOR GENE; SIGMOIDOSCOPY; STOMACH CANCER; TURCOT SYNDROME;

EID: 20444413060     PISSN: 10431489     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.scrs.2005.02.001     Document Type: Article

References (109)

1. P.H. Sugarbaker, L.L. Gunderson, R.E. Wittes Colorectal Cancer V.T. DeVita S. Hellman S.A. Rosenberg Cancer Principles and Practices of Oncology 1985 Lippincott Philadelphia, PA 800 803
2. B.A. Ponder, M.M. Wilkinson Direct examination of the clonality of carcinogen-induced colonic epithelial dysplasia in chimeric mice J Natl Cancer Inst 77 1986 967 976
3. P.M. Calvert, H. Frucht The genetics of colorectal cancer Ann Intern Med 137 2002 608 612
4. E.R. Fearon, B. Vogelstein A genetic model for colorectal tumorigenesis Cell 61 1990 759 767
5. J.I. Allen Molecular biology of colon cancer a clinician's view Perspect Colon Rectal Surg 8 1995 181 202
6. F. Piard, C. Chapusot, A. Ecarnot-Laubriet Molecular markers of heterogeneity in colorectal cancers and adenomas Eur J Cancer Prev 11 2002 85 97
7. H. Fukunari, T. Iwama, K. Sugihara Intratumoral heterogeneity of genetic changes in primary colorectal carcinomas with metastasis Surg Today 33 2003 408 413
8. R. Ward, A. Meagher, I. Tomlinson Microsatellite instability and the clinicopathological features of sporadic colorectal cancer Gut 48 2001 821 829
9. A. Lindblom Different mechanisms in the tumorigenesis of proximal and distal colon cancers Curr Opin Oncol 13 2001 63 69
10. K.W. Kinzler, M.C. Nilbert, B. Vogelstein Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers Science 251 1991 1366 1370
11. K.W. Kinzler, M.C. Nilbert, L.-K. Su Identification of FAP locus genes from chromosome 5q21 Science 253 1991 661 665
12. M. Miyaki, M. Konishi Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors Cancer Res 54 1994 3011 3022
13. K.W. Kinzler, B. Vogelstein Landscaping the cancer terrain Science 280 1998 1036 1037
14. S. Munemitsu, B. Souza, O. Muller The APC gene product associates with microtubules in vivo and promotes their assembly in vitro and thus may play a role in mitosis and apoptosis Cancer Res 54 14 1994 3676 3681
15. D.M. Livingston Cancer Chromosome defects in the colon Nature 410 2001 536 537
16. R. Fodde, J. Kuipers, C. Rosenberg Mutations in the APC tumour suppressor gene cause chromosomal instability Nat Cell Biol 3 2001 433 438
17. H. Lamlum, A. Papadopoulou, M. Ilyas APC mutations are sufficient for the growth of early colorectal adenomas PNAS 97 2000 2225 2228
18. S. Munemitsu, I. Albert, B. Souza Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein Proc Natl Acad Sci USA 92 1995 3046 3050
19. J. Deka, J. Kuhlmann, O. Muller A domain within the tumor suppressor protein APC shows very similar biochemical properties as the microtubule-associated protein tau Eur J Biochem 253 1998 591 597
20. M. Peifer Enhanced β-catenin as oncogene - the smoking gun Science 275 1997 1752
21. J.I. Fenton, M.S. Wolff, M.W. Orth Membrane-type matrix metalloproteinases mediate curcumin-induced cell migration I non-tumorigenic colon epithelial cells differing in APC genotype Carcinogenesis 23 2002 1065 1070
22. E.R. Fearon, K.R. Cho, J.M. Nigro Identification of a chromosome 18q gene that is altered in colorectal cancers Science 247 1990 49 56
23. E.R. Fearon, K.R. Cho, J.M. Nigro Identification of a chromosome 18q gene that is altered in colorectal cancers Science 247 1990 49 56
24. P. Mehlen, S. Rabizadeh, S.J. Snipas The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis Nature 395 1998 801 804
25. K. Inokuchi, H. Yamaguchi, H. Hanawa Loss of DCC gene expression is of prognostic importance in acute myelogenous leukemia Clin Cancer Res 8 2002 1882 1888
26. M. Reyes-Mugica, P. Lin, J. Yokota Status of deleted in colorectal cancer gene expression correlates with neuroblastoma metastasis Nat Lab Invest 78 1998 669 675
27. J. Jen, H. Kim, S. Piantadosi Allelic loss of chromosome 18q and prognosis in colorectal cancer N Engl J Med 331 1994 213 221
28. D. Shibata, M.A. Reale, P. Lavin The DCC protein and prognosis in colorectal cancer N Engl J Med 335 1996 1727 1732
29. O.A. Ogunbiyi, P.J. Goodfellow, K. Herfarth Prognostic value of chromosome 1p allelic loss in colon cancer J Clin Oncol 113 1997 761 766
30. E. Martinez-Lopez, A. Abad, A. Font Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer Gastroenterology 114 1998 1180 1187
31. S. Huerta, E.S. Srivatsan, N. Venkatesan Human colon cancer cells deficient in DCC produce abnormal transcripts in progression of carcinogenesis Dig Dis Sci 46 2001 188
32. J.M. Carethers, M.T. Hawn, J.K. Greenson Prognostic significance of allelic lost at chromosome 18q21 for stage II colorectal cancer Gastroenterology 114 1998 1180 1187
33. R.S. Houlston What we could do now molecular pathology of colorectal cancer J Clin Pathol Mol Pathol 54 2001 206 214
34. A.J. Levine, J. Momand, C.A. Finlay The p53 tumor suppressor gene Nature 351 1991 453 456
35. S.J. Baker, A.C. Preisinger, J.M. Jessup p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis Cancer Res 50 1990 7717 7722
36. E. Darmon, K. Cleary, M.J. Wargovich Immunohistochemical analysis of p53 overexpression in human colonic tumors Cancer Detect Prev 18 1994 187 195
37. H.S. Goh, C.S. Chan, K. Khine p53 and behavior of colorectal cancer Lancet 344 1994 233 234
38. K. Ookawa, M. Sakamoto, S. Hirohashi Concordant p53 and DCC alterations and allelic losses on chromosomes 13 and 14q associated with liver metastases of colorectal carcinoma Int J Cancer 53 1993 382 387
39. V.E. Pricolo, S.D. Finkelstein, K. Hansen Mutated p53 gene is an independent adverse predictor of survival in colon carcinoma Arch Surg 132 1997 371 375
40. U. Kressner, M. Inganas, S. Byding Prognostic value of p53 genetic changes in colorectal cancer J Clin Oncol 17 1999 593 599 PMID 10080604
41. M. Loda, B. Cukor, S.W. Tam Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas Nat Med 3 1997 231 234
42. R. Palmqvist, R. Stenling, A. Oberg Prognostic significance of p27(Kip1) expression in colorectal cancer a clinico-pathological characterization J Pathol 1988 1999 18 23
43. D.F. Liu, K. Ferguson, G.S. Cooper p27 cell-cycle inhibitor is inversely correlated with lymph node metastases in right-sided colon cancer J Clin Lab Anal 13 1999 291 295
44. M.L. Slattery, K. Curtin, K. Anderson Associations between dietary intake and Ki-ras mutations in colon tumors a population-based study Cancer Res 60 2000 6935 6941
45. F. Piard, C. Chapusot, A. Ecarnot-Laubriet Molecular markers of heterogeneity in colorectal cancers and adenomas Eur J Cancer Prevent 11 2002 85 97
46. A.J. Smith, H.S. Sterms, M. Penner Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons Cancer Res 54 1994 5527 5530
47. J.M. Chiang, Y.H. Chou, T.B. Chou K-ras codon 12 mutation determines the polypoid growth of colorectal cancer Cancer Res 58 15 1998 3289 3293
48. T. Fujimori, K. Satonaka, Y. Yamamura-Idei Non-involvement of ras mutations in flat colorectal adenomas and carcinomas Int J Cancer 57 1994 51 55
49. J.M. Chiang Role of K-ras mutations in colorectal carcinoma Cancer Lett 126 1998 179 185
50. W.A. Bleeker, V.M. Hayes, A. Karrenbeld Impact of KRAS and TP53 mutations on survival in patients with left-and right-sided Dukes' C colon cancer Am J Gasteroenterol 95 10 2000 2953 2957
51. S.D. Finkelstein, R. Sayegh, S. Christensen Genotypic classification of colorectal adenocarcinoma. Biologic behavior correlates with K-ras-2 mutation type Cancer 71 1993 3827 3838
52. P. Moerkerk, J.W. Arends, M. van Driel Type and number of Ki-ras point mutations relate to stage of human colorectal cancer Cancer Res 54 1994 3376 3378
53. M. Span, P.T. Moerkerk, A.F. De Goeij A detailed analysis of K-ras point mutations in relation to tumor progression and survival in colorectal cancer patients Int J Cancer 69 1996 241 245
54. J. Benhattar, L. Losi, P. Chaubert Prognostic significance of K-ras mutations in colorectal carcinoma Gastroenterology 104 1993 1044 1048
55. S.M. Bell, N. Scott, D. Cross Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer Gastroenterology 104 1993 57 64
56. V.E. Pricolo, S.D. Finkelstein, T.T. Wu Prognostic value of TP53 and K-ras-2 mutational analysis in stage III carcinoma of the colon Am J Surg 171 1996 41 46
57. H.J. Andreyev, A.R. Norman, D. Cunningham Kirsten ras mutations in patients with colorectal cancer the multicenter "RASCAL" study J Natl Cancer Inst 90 1998 675 684
58. E. Villa, A. Dugani, A.M. Rebecchi Identification of subjects at risk for colorectal carcinoma through a test based on K-ras determination in the stool Gastroenterology 110 5 1996 1346 1353 May
59. R.A. Barnetson, P. Symons, B.G. Robinson Genetic analysis of multiple sporadic colon carcinomas from a single patient Int J Colorectal Dis 14 2000 83 86
60. S. Salahshor, U. Kressner, L. Pahlman Colorectal cancer with and without microsatellite instability involves different genes Genes Chromosomes Cancer 26 1999 247 252
61. S. Forster, H.P. Sattler, M. Hack Microsatellite instability in sporadic carcinomas of the proximal colon association with diploid DNA content, negative protein expression of p53, and distinct histomorphologic features Surgery 123 1998 13 18
62. V.J. Bubb, L.J. Curtis, C. Cunningham Microsatellite instability and the role of hMSH2 in sporadic colorectal cancer Oncogene 12 1996 2641 2649
63. J.T. Johannsdottir, J.T. Bergthorsson, S. Gretarsdottir Replication error in colorectal carcinoma association with loss of heterozygosity at mismatch repair loci and clinicopathological variables Anticancer Res 19 1999 1821 1826
64. M.J. Massa, P. Iniesta, R. Gonzalez-Quevado Differential prognosis of replication error phenotype and loss of heterozygosity in sporadic colorectal cancer Eur J Cancer 35 1999 1676 1682
65. R. Gryfe, H. Kim, E.T. Hsieh Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer N Engl J Med 342 2000 69 77
66. Jernvall P, Makinen MJ, Karttunen TJ,, et al. Microsatellite instability: impact on cancer progression in proximal and distal colorectal cancers. Eur J Cancer 35:197-201
67. H. Elsaleh, B. Powell, P. Soontrapornchai p53 gene mutation, microsatellite instability and adjuvant chemotherapy impact on survival of 388 patients with Dukes' C colon carcinoma Oncology 58 2000 52 59
68. C.M. Wright, O.F. Dent, M. Barker Prognostic significance of extensive microsatellite instability in sporadic clinicopathological stage C colorectal cancer Br J Surg 87 2000 1197 1202
69. L. Lipton, S.E. Halford, V. Johnson Carcinogenesis in MYH-associated polyposis follows a distinct genetic pathway Cancer Res 63 2003 7595 7599
70. R.P. Bissonnette, F. Echeverri, A. Mahboubi Apoptotic cell death induced by c-myc and inhibited by bcl-2 Nature 359 1992 552 554
71. M. Kang, H. Mitomi, M. Sada Ki-67, p53, and Bcl-2 expression of serrated adenomas of the colon Am J Surg Pathol 21 1997 471-423
72. Q.-L. Lu, R. Poulsom, L. Wong Bcl-2 expression in adult and embryonic non-haematopoietic tissues J Pathol 169 1993 431 437
73. F.A. Sinicrope, S.B. Ruan, K.R. Cleary Bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis Cancer Res 55 1995 237 241
74. A. Hague, M. Moorghen, D. Hicks BCL-2 expression in human colorectal adenomas and carcinomas Oncogene 9 1994 3367 3370
75. B. Bonnotte, N. Favre, M. Moutet Bcl-2-mediated inhibition of apoptosis prevents immunogenicity and restores tumorigenicity of spontaneously regressive tumors J Immunol 161 1998 1433 1438
76. S.H.N. Meterissian, M. Kontogiannea, M. Al-Sowaidi Bcl-2 is a useful prognostic marker in Dukes' B colon cancer Ann Surg Oncol 8 2001 533 537
77. J.M. Bhatavdekar, D.D. Patel, N. Ghosh Coexpression of Bcl-2, c-Myc, and p53 oncoproteins as prognostic discriminants in patients with colorectal carcinoma Dis Colon Rectum 40 1997 785 790
78. F.A. Sinicrope, J. Hart, H.A. Hsu Apoptotic and mitotic indices predict survival rates in lymph node-negative colon carcinomas Clin Cancer Res 5 1999 1793 1804
79. G. Kouraklis, J. Kakisis, S. Theoharis Prognostic significance and correlation with survival of bcl-2 and TGF-β RII in colon cancer Digest Dis Sci 48 2003 2284 2289
80. A. Webb, D. Cunningham, F. Cotter BCL-2 antisense therapy in patients with non-Hodgkin lymphoma Lancet 349 1997 1137 1141
81. G. Tortora, R. Caputo, V. Damiano Combined blockade of protein kinase A and Bcl-2 by antisense strategy induces apoptosis and inhibits tumor growth and angiogenesis Clin Cancer Res 7 2001 2537 2544
82. G. Tortora, R. Caputo, V. Damiano Combined targeted inhibition of bcl-2, bcl-XL, epidermal growth factor receptor, and protein kinase A type I causes potent antitumor, apoptotic, and antiangiogenic activity Clin Cancer Res 9 2003 866 871
83. J. Folkman The role of angiogenesis in tumor growth Semin Cancer Biol 3 1992 65 71
84. X. Zhang, J.P. Gaspard, D.C. Chung Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia Cancer Res 61 2001 6050 6054
85. L. Ellis, Y. Takahashi, W. Liu Vascular endothelial growth factor in human colon cancer biology and therapeutic implications Oncology 5 2000 11 15
86. V. Easwaran, S.H. Lee, L. Inge β-catenin regulates vascular endothelial growth factor expression in colon cancer Cancer Res 63 2003 3145 3153
87. N. Ferrara Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis therapeutic implications Semin Oncol 29 2002 10 14
88. A.S. Tarnawski, M.K. Jones Inhibition of angiogenesis by NSAIDs molecular mechanisms and clinical implications J Mol Med 81 2003 627 636
89. M.I. Shtivelband, H.S. Juneja, S. Lee Aspirin and salicylate inhibit colon cancer medium- and VEGF-induced endothelial tube formation correlation with suppression of cyclooxygenase-2-expression J Thrombosis Haemostasis 1 2003 2225 2233
90. M.J. Thun, M.M. Namboodiri, C.W. Heath Jr. Aspirin use and reduced risk of fatal colon cancer NEJM 55 1991 1464 1472
91. O. Stoeltzing, W. Liu, N. Reinmuth Angiogenesis and antiangiogenic therapy of colon cancer liver metastasis Ann Surg Oncol 10 2002 722 733
92. H. Sato, T. Takino, Y. Okada A matrix metalloproteinase expressed on the surface of invasive tumour cells Nature 371 1994 61 65
93. S. Malhotra, E. Newman, D. Eisenberg Increased membrane type 1 matrix metalloproteinase expression from adenoma to colon cancer Dis Colon Rectum 45 2002 537 543
94. T. Tomita, K. Iwata Matrix metalloproteinases and tissue inhibitors of metalloproteinases in colonic adenomas-adenocarcinomas Dis Colon Rectum 39 1996 1255 1264
95. D.L. Ornstein, K.H. Cohn Balance between activation and inhibition of matrix metalloproteinase-2 (MMP-2) is altered in colorectal tumors compared to normal colonic epithelium Dig Dis Sci 47 2002 1821 1830
96. I.S. Nathke, C.L. Adams, P. Polakis The adenomatous polyposis coli tumor suppressor protein localizes to plasma membrane sites involved in active cell migration J Cell Biol 134 1996 165 179
97. Y. Adachi, H. Yamamoto, F. Itoh Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers Gut 45 1999 252 258
98. M. Mori, G.F. Barnard, K. Mimori Overexpression of matrix metalloproteinase-7 mRNA in human colon carcinomas Cancer 75 1995 1516 1519
99. T. Ishikawa, Y. Ichikawa, M. Mitsuhashi Matrilysin is associated with progression of colorectal tumor Cancer Lett 107 1996 5 10
100. Y. Adachi, H. Yamamoto, F. Itoh Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers Gut 45 1999 252 258
101. N. Mitsiades, W. Yu, V. Poulaki Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity Cancer Res 61 2001 577 581
102. H. Ishida, N. Murata, M. Tada Determining the levels of matrix metalloproteinase-9 in portal and peripheral blood is useful for predicting liver metastasis of colorectal cancer Jpn J Clin Oncol 33 2003 186 191
103. P.J. Morin, A.B. Sparks, V. Korinek Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC Science 275 1997 1787 1790
104. A.B. Sparks, P.J. Morin, B. Vogelstein Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer Cancer Res 58 1998 1130 1134
105. S. Munemitsu, I. Albert, B. Souza Regulation of intracellular β-catenin levels by the adenomatous polyposos coli (APC) tumor-suppressor gene PNAS 92 1995 3046 3050
106. M. Pignatelli, D. Liu, M.M. Nasim Morphoregulatory activities of E-cadherin and beta-1 integrins in colorectal tumour cells Br J Cancer 66 1992 629 634
107. T. Kanazawa, T. Watanabe, S. Kazama Poorly differentiated adenocarcinoma and mucinous carcinoma of the colon and rectum show higher rates of loss of heterozygosity and loss of E-cadherin expression due to methylation of promoter region Int J Cancer 102 2002 225 229
108. B.M. Berger, L. Robison, J. Glickman Colon cancer-associated DNA mutations Marker selection for the detection of proximal colon cancer Diagn Mol Pathol 12 4 2003 187 192
109. Y. Wang, T. Jatkoe, Y. Zhang Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer J Clin Oncol 22 2004 1564 1571